Deep learning based automatic segmentation of the Internal Pudendal Artery in definitive radiotherapy treatment planning of localized prostate cancer.

Automatic Segmentation Deep learning Erectile Dysfunction Internal Pudendal Artery (IPA) Prostate cancer

Journal

Physics and imaging in radiation oncology
ISSN: 2405-6316
Titre abrégé: Phys Imaging Radiat Oncol
Pays: Netherlands
ID NLM: 101704276

Informations de publication

Date de publication:
Apr 2024
Historique:
received: 12 12 2023
revised: 06 04 2024
accepted: 08 04 2024
medline: 6 5 2024
pubmed: 6 5 2024
entrez: 6 5 2024
Statut: epublish

Résumé

Radiation-induced erectile dysfunction (RiED) commonly affects prostate cancer patients, prompting clinical trials across institutions to explore dose-sparing to internal-pudendal-arteries (IPA) for preserving sexual potency. IPA, challenging to segment, isn't conventionally considered an organ-at-risk (OAR). This study proposes a deep learning (DL) auto-segmentation model for IPA, using Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) or CT alone to accommodate varied clinical practices. A total of 86 patients with CT and MRI images and noisy IPA labels were recruited in this study. We split the data into 42/14/30 for model training, testing, and a clinical observer study, respectively. There were three major innovations in this model: 1) we designed an architecture with squeeze-and-excite blocks and modality attention for effective feature extraction and production of accurate segmentation, 2) a novel loss function was used for training the model effectively with noisy labels, and 3) modality dropout strategy was used for making the model capable of segmentation in the absence of MRI. Test dataset metrics were DSC 61.71 ± 7.7 %, ASD 2.5 ± .87 mm, and HD95 7.0 ± 2.3 mm. AI segmented contours showed dosimetric similarity to expert physician's contours. Observer study indicated higher scores for AI contours (mean = 3.7) compared to inexperienced physicians' contours (mean = 3.1). Inexperienced physicians improved scores to 3.7 when starting with AI contours. The proposed model achieved good quality IPA contours to improve uniformity of segmentation and to facilitate introduction of standardized IPA segmentation into clinical trials and practice.

Sections du résumé

Background and purpose UNASSIGNED
Radiation-induced erectile dysfunction (RiED) commonly affects prostate cancer patients, prompting clinical trials across institutions to explore dose-sparing to internal-pudendal-arteries (IPA) for preserving sexual potency. IPA, challenging to segment, isn't conventionally considered an organ-at-risk (OAR). This study proposes a deep learning (DL) auto-segmentation model for IPA, using Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) or CT alone to accommodate varied clinical practices.
Materials and methods UNASSIGNED
A total of 86 patients with CT and MRI images and noisy IPA labels were recruited in this study. We split the data into 42/14/30 for model training, testing, and a clinical observer study, respectively. There were three major innovations in this model: 1) we designed an architecture with squeeze-and-excite blocks and modality attention for effective feature extraction and production of accurate segmentation, 2) a novel loss function was used for training the model effectively with noisy labels, and 3) modality dropout strategy was used for making the model capable of segmentation in the absence of MRI.
Results UNASSIGNED
Test dataset metrics were DSC 61.71 ± 7.7 %, ASD 2.5 ± .87 mm, and HD95 7.0 ± 2.3 mm. AI segmented contours showed dosimetric similarity to expert physician's contours. Observer study indicated higher scores for AI contours (mean = 3.7) compared to inexperienced physicians' contours (mean = 3.1). Inexperienced physicians improved scores to 3.7 when starting with AI contours.
Conclusion UNASSIGNED
The proposed model achieved good quality IPA contours to improve uniformity of segmentation and to facilitate introduction of standardized IPA segmentation into clinical trials and practice.

Identifiants

pubmed: 38707629
doi: 10.1016/j.phro.2024.100577
pii: S2405-6316(24)00047-2
pmc: PMC11068618
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100577

Informations de copyright

© 2024 University of Texas Southwestern Medical Center.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Anjali Balagopal (A)

Medical Artificial Intelligence and Automation (MAIA) Laboratory and Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Michael Dohopolski (M)

Medical Artificial Intelligence and Automation (MAIA) Laboratory and Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Young Suk Kwon (Y)

Medical Artificial Intelligence and Automation (MAIA) Laboratory and Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Steven Montalvo (S)

Medical Artificial Intelligence and Automation (MAIA) Laboratory and Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Howard Morgan (H)

Medical Artificial Intelligence and Automation (MAIA) Laboratory and Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Ti Bai (T)

Medical Artificial Intelligence and Automation (MAIA) Laboratory and Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Dan Nguyen (D)

Medical Artificial Intelligence and Automation (MAIA) Laboratory and Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Xiao Liang (X)

Medical Artificial Intelligence and Automation (MAIA) Laboratory and Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Xinran Zhong (X)

Medical Artificial Intelligence and Automation (MAIA) Laboratory and Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Mu-Han Lin (MH)

Medical Artificial Intelligence and Automation (MAIA) Laboratory and Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Neil Desai (N)

Medical Artificial Intelligence and Automation (MAIA) Laboratory and Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Steve Jiang (S)

Medical Artificial Intelligence and Automation (MAIA) Laboratory and Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Classifications MeSH